On Invalid Date, Merus Nv (NASDAQ: MRUS) reported Q4 2023 earnings per share (EPS) of -$1.09, up 39.78% year over year. Total Merus Nv earnings for the quarter were -$60.15 million. In the same quarter last year, Merus Nv's earnings per share (EPS) was -$1.81.
As of Q2 2024, Merus Nv's earnings has grown year over year. Merus Nv's earnings in the past year totalled -$154.94 million.
What is MRUS's earnings date?
Merus Nv's earnings date is Invalid Date. Add MRUS to your watchlist to be reminded of MRUS's next earnings announcement.
What was MRUS's revenue last quarter?
On Invalid Date, Merus Nv (NASDAQ: MRUS) reported Q4 2023 revenue of $8.94 million up 16.19% year over year. In the same quarter last year, Merus Nv's revenue was $10.67 million.
What was MRUS's revenue growth in the past year?
As of Q2 2024, Merus Nv's revenue has grown 5.68% year over year. This is 142.96 percentage points lower than the US Biotechnology industry revenue growth rate of 148.64%. Merus Nv's revenue in the past year totalled $43.95 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.